Table 4

Percentage of persons with prescribed drugs in 2020 by specialist care*

TotalNoneRheumatologyPulmonologyBoth
N1484321379244540
Age, mean, years (SD)72 (10)75 (10)72 (10)71 (10)71 (10)
31–50 (%)2.40.91.62.53.9
51–70 (%)3933374540
>70 (%)5966625356
Female (%)6968746567
Glucocorticoids6858706674
Any csDMARD5540644364
 Methotrexate3325392337
 Leflunomide105.0147.812
 HCQ8.25.67.74.912
 Mycophenolate2.11.91.63.71.9
 Sulfasalazine0.50.01.30.40.2
Any bDMARD2413311829
 TNF inhibitor117.8129.413
 Abatacept62.26.33.38.0
 Rituximab2.70.03.40.84.6
 Tocilizumab3.81.96.33.33.5
JAK inhibitor6.53.48.42.98.7
NSAIDs3834393939
Analgesics4446484142
Opioids3039322126
Nintedanib2.20.30.34.04.0
Pirfenidone0.40.30.80.6
  • *At least one contact to the corresponding specialist in 2020.

  • cs/bDMARD, conventional synthetic/biological disease-modifying antirheumatic drug; HCQ, hydroxychloroquine; JAK, Janus kinase; NSAIDs, non-steroidal anti-inflammatory drugs; TNF, tumour necrosis factor.